2018 Medicare Reimbursement Changes for Oncology Programs
Join this webconference to learn about our latest analysis on Medicare payment updates for cancer services—including the 340B program, site neutrality, and the hospital outpatient prospective payment system (HOPPS).
Our oncology experts will review the reimbursement changes for chemotherapy, radiation therapy, and imaging -- and then consider their impact on your provider customers’ strategic and operational goals for 2018. This presentation covers in-depth reimbursement changes for chemotherapy, radiation therapy, and imaging.
Things You’ll Learn:
- How Medicare reimbursement for outpatient cancer services will change in 2018
- How changes in reimbursement and regulations are affecting cancer programs
- How providers are modifying their cancer program strategy and operations in response
Presenters: De Saulet and Kate Wister
Not an Advisory Board member? You can still join us for this webconference. Register here